MedicalResearch.com Interview with:
Professor Mark L. Wahlqvist, M.D., Ph.D.
Institute of Population Health Sciences, National Health Research Institutes, Taiwan
National Defense Medical Center, School of Public Health, Taiwan
Monash Asia Institute, Monash University Melbourne, Australia
Medical Research: What are the main findings of the study?
Prof. Wahlqvist: Poor appetite and dietary quality as judged by diversity separately (each by about 50%) and together (by about 80%) increase the mortality risk in older persons living in the community.
MedicalResearch.com Interview with:
Shadi Rashtak, MD
Department of Dermatology
Mayo Clinic College of Medicine
Rochester, Minnesota
Medical Research: What are the main findings of the study?
Dr. Rashtak: We found that among a population of mainly acne patients those who received isotretinoin had a lower risk of inflammatory bowel disease as compared to those who did not take this medication. We carefully reviewed the medical records of patients to ensure that this finding was not simply because the drug was avoided in patients with a previous personal or family history of IBD.
MedicalResearch.com Interview with:
Hayley Gershengorn MD
Assistant Professor, Department of Medicine (Critical Care)
Assistant Professor, The Saul R. Korey Department of Neurology
Albert Einstein College of Medicine
Bronx, NY 10461
Medical Research: What are the main findings of the study?
Dr. Gershengorn: Using a large national database, we found there to be no association between the use of arterial catheters and mortality in mechanically ventilated medical intensive care unit patients. Similarly, we found no beneficial association between arterial catheters and mortality in any of the eight other critically ill subgroups evaluated.
MedicalResearch.com Interview with:
Allison Weinmann MBBS, FRACP
Senior Staff, Division Infectious Diseases
Director HFHS Immunization Team
Medical Director Infection Control and Prevention, West Bloomfield Hospital
Henry Ford Health System
Clinical Assistant Professor, Wayne State University
Detroit, Mi 48202
Medical Research: What are the main findings of this study?
Dr. Weinmann: The main findings included:
MedicalResearch.com Interview with:
Mintu Turakhia, MD MAS, FHRS FACC FAHA
Assistant Professor of Medicine and (by courtesy) of Health Research & Policy
Stanford University School of Medicine
Director of Cardiac Electrophysiology
Core Investigator, Center for Innovation to Implementation
VA Palo Alto Healthcare System
Medical Research: What are the main findings of the study
Dr. Turakhia: We found that the reported success rate of a study correlated with the number of times the study was cited in the literature, even after adjustment for a wide range of factors.
MedicalResearch.com Interview with:
Achih H. Chen, MD, FACS, FAACS
Georgia Center for Facial Plastic Surgery, Evans, Ga and the Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology–Head and Neck Surgery
Georgia Regents University, August, Ga
Medical Research: What is the significance of the study?
Dr. Chen : This is the first time that facial rejuvenation surgery using surgical approaches in three planes combined with ablative resurfacing has been reported in the medical literature. This approach was not previously thought possible in a single surgical setting because of the concern about disrupting the facial blood supply that may result in loss of the skin. The study demonstrates the safety of this “Total Face” approach. This approach allows simultaneous tightening of the jawline and neck, recreating the lost youthful volume of the midface region, and restoring of the smooth skin texture so characteristic of a young face. This allows for a more complete or “Total Face Rejuvenation” for patients while allowing them the flexibility for a single recovery period or downtime.
MedicalResearch.com Interview with:
Dr. Sonja Yokum Ph.D.
Oregon Research Institute
Eugene Oregon, 97403
Medical Research: What are the main findings of the study?
Dr. Yokum: We found that adolescents showing elevated responses in reward regions to food commercials gained more weight over 1-year follow-up compared to those with less activation in these brain regions. This suggests that there are individual differences in neural vulnerability to food commercials that appear to identify youth at risk for excess weight gain.
MedicalResearch.com Interview with:
Sophie Billioti de Gage PharmD
University of Bordeaux Segalen
France
Medical Research: What are the main findings of the study?
Answer: The risk of Alzheimer’s disease was found increased by 43-51% in persons (>65) having initiated a treatment with benzodiazepines in the past (>5 years before). Risk increased with the length of exposure and when long acting benzodiazepines were used.
MedicalResearch.com Interview with:
Saurabh S. Thosar, Ph.D.,
Postdoctoral Researcher
Oregon Institute for Occupational Health Sciences,
Oregon Health & Science University
Medical Research: What are the main findings of the study?
Dr. Thosar: We discovered that 3 hours of sitting leads to an impairment in shear rate and an impairment in femoral artery endothelial function. When systematic breaks are added in the sitting time the shear rate and the endothelial function are preserved.
MedicalResearch.com Interview with:
Michael Johansen, MD MS
Assistant Professor
Dept of Family Medicine
Ohio State University
Medical Research: What are the main findings of the study?
Dr. Johansen: Between 2007-2011, the United States spent $63.4 billion on high-cost proton pump inhibitors of which $47.1 billion was in excess of using generic omeprazole.
MedicalResearch.com Interview with:
Professor Yuli Huang
The First People's Hospital of Shunde, Daliang Town, China, and colleagues
Medical Research: What are the main findings of the study?
Professor Huang: In this meta-analysis of 16 prospective cohort studies comprising more than 890,000 individuals, we found that the presence of prediabetes at baseline associated with a 15% increased risk of cancer overall. The results were consistent across cancer endpoint, age, duration of follow-up and ethnicity. There was no significant difference for the risk of cancer with different definitions of prediabetes (impaired fasting glucose [IFG] and/or impaired glucose tolerance [IGT]).
MedicalResearch.com Interview with:
Carolyn J. Crandall, MD, MS
Professor of Medicine
David Geffen School of Medicine at University of California,
Los Angeles
Medical Research: What are the main findings of the study?
Dr. Crandall:
1. We found high-strength evidence that several medications decrease fracture risk when used by persons with bone density in the osteoporotic range and/or with pre-existing hip or vertebral fracture. While many of the medications (alendronate, risedronate, zoledronic acid, ibandronate, denosumab, teriparatide, and raloxifene) reduce vertebral fractures, a reduction in the risk of hip fracture is not demonstrated for all of the medications. In particular, hip fracture reduction is only demonstrated for alendronate, risedronate, zoledronic acid, and denosumab. Unfortunately, due to a lack of head-to-head trials, the comparative effectiveness of the medications is unclear.
2. The adverse effects of the medications vary. For example, raloxifene is associated with an increased risk of thromboembolic events, whereas denosumab and the bisphosphonate medications have been associated with increased risk of osteonecrosis of the jaw and atypical subtrochanteric femoral fractures.
MedicalResearch.com Interview with:
Steffie Woolhandler MD MPH
Professor School of Public Health and Hunter College, CUNY;
Professor of Medicine
Harvard Medical School Cambridge Hospital
Medical Research: What are the main findings of the study?
Dr. Woolhandler: In 2011, U.S. hospitals spent $215 billion on
billing and administration. Meanwhile, other
countries spent far less. None of the other
seven countries we studied spent even half as
much as the U.S., and they all have modern, high
quality hospitals. While we spent nearly
$700 per capita on hospital paperwork, Scotland
and Canada spent less than $200. This means
that if U.S. hospitals ran as efficiently as
Canada’s, the average family of four would save
$2,000 annually on health care.
Stephen H. Gillespie, M.D., D.Sc
University of St. Andrews Medical School, St. Andrews
Medical Research: What are the main findings of the study?
Dr. Gillespie: REMox TB was a pioneering trial that has shown that a large-scale trial can be run efficiently in resource-poor settings with a high TB burden, adhere to the highest standards of good clinical trial practices, and deliver a clear, unequivocal result. REMoxTB was among the most rigorous Tuberculosis drug trials ever conducted in the modern era of TB treatment and among the largest ever conducted for a new TB treatment. It enrolled 1,931 patients at 50 sites in nine countries, mostly in Africa and Asia. Previously, there were thought to be regional differences in way in which patients' response to treatment across the world but we showed that a rigorous approach to trial conduct there was no evidence for that difference.
The study confirmed that daily moxifloxacin was safe over four months of therapy and the moxifloxacin containing arms were more bactericidal initially. Despite its substantial anti-TB activity it did not prove possible to shorten therapy to four months. .
These findings, with the safety of moxifloxacin, and its activity against TB, support the continued clinical testing of moxifloxacin as a component of other novel regimens.
MedicalResearch.com Interview with:
Dr. Claire Sexton Ph.D.
University of Oxford
Medical Research: What are the main findings of the study?
Dr. Sexton: We found that sleep difficulties (which can include trouble falling asleep, waking up during the night, or waking up too early) were associated with an increased rate of decline in brain volumes over 3-5 years.
MedicalResearch.com: Interview with:
Elena Ramírez, MD, PhD
Clinical Pharmacology Department
Hospital Universitario la Paz, IdiPaz
School of Medicine, U.A.M.
Medical Research: What are the main findings of the study?
Dr. Ramirez: We found that the presence of a past history of allergy, the use of proton pump inhibitors (PPI), the number of times of previous administration of contrast media , and high values of creatinine are significant factors to hypersensitivity reactions to contrast media (CM). We found a low, but relevant, number of positive skin tests. The tolerability of an alternative skin test-negative contrast media or different contrast media was confirmed in all cases.
MedicalResearch.com Interview with:
Sean Clouston Ph.D.
Assistant Professor
Core Faculty, Program in Public Health
Department of Preventive Medicine
Stony Brook University Health Sciences Center
Stony Brook, NY 11794
Medical Research: What is the background for this study:
Dr. Clouston: A number of epidemiological studies have found that suicide rates have decreased rapidly with the widespread distribution of SSRI antidepressants. Our group has found that proliferation of preventive medicine has, with regard to other causes of death, tended to occur unequally. We hypothesized that if SSRI antidepressants prevent suicide by treating depression, then suicide might also be susceptible to such inequality. Our study used mortality data to show that decreases in suicide were concentrated in regions with higher socioeconomic status.
Medical Research: What are the main findings of the study?
Dr. Clouston We used the best available data from the US and found that socioeconomic inequalities have increased dramatically in conjunction with the proliferation of SSRI antidepressants.
MedicalResearch.com Interview with:
Faleh Tamimi, BDS, PhD
Assistant Professor,
Faculty of Dentistry
Strathcona Anatomy & Dent,
Montreal, Quebec Canada
Medical Research: What are the main findings of the study?
Dr. Tamimi: The main finding was that SSRIs usage was associated with an increased risk of dental implants failure.